Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_assertion type Assertion NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_head.
- NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_assertion description "[TLR4 ligands have received attention as immunotherapies; therefore, we assessed the expression of TLR4 in human melanoma specimens (29 primary lesions and 28 metastatic lesions) representing different types of melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_provenance.
- NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_assertion evidence source_evidence_literature NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_provenance.
- NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_assertion SIO_000772 25175033 NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_provenance.
- NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_assertion wasDerivedFrom befree-2016 NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_provenance.
- NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_assertion wasGeneratedBy ECO_0000203 NP1215584.RAc9bBAkpZ3B17_uhziPcHp5X0oUH8SxAsnbJezH648j8130_provenance.